Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos
Flavia Novelli, Angela Bononi, Qian Wang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 48
Open Access | Times Cited: 23

Showing 23 citing articles:

Apoptotic cell death in disease—Current understanding of the NCCD 2023
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 210
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations
Michele Carbone, Harvey I. Pass, Güntülü Ak, et al.
Journal of Thoracic Oncology (2022) Vol. 17, Iss. 7, pp. 873-889
Open Access | Times Cited: 67
The Interplay of Hypoxia Signaling on Mitochondrial Dysfunction and Inflammation in Cardiovascular Diseases and Cancer: From Molecular Mechanisms to Therapeutic Approaches
Esmaa Bouhamida, Giampaolo Morciano, Mariasole Perrone, et al.
Biology (2022) Vol. 11, Iss. 2, pp. 300-300
Open Access | Times Cited: 38
Did the Ban on Asbestos Reduce the Incidence of Mesothelioma?
Michele Carbone, Haining Yang, Harvey I. Pass, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 6, pp. 694-697
Open Access | Times Cited: 16
Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer
Natsumi Tsuboyama, Ru Wang, Aileen Patricia Szczepanski, et al.
Oncogene (2022) Vol. 41, Iss. 15, pp. 2152-2162
Open Access | Times Cited: 25
Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?
Klara Horáčková, Markéta Janatová, Petra Kleiblová, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17020-17020
Open Access | Times Cited: 11
Bayesian analysis of the rate of spontaneous malignant mesothelioma among BAP1 mutant mice in the absence of asbestos exposure
Dahlia M. Nielsen, Mei Hsu, M. Zapata, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
An overview of BAP1 biological functions and current therapeutics
Abdelrahman M. Elsayed, Muaiad Kittaneh, Colleen M. Cebulla, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189267-189267
Open Access
Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma
Michele Carbone, Michael Minaai, Yasutaka Takinishi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology
Georgia Karpathiou, Michel Péoc’h, Anand Sundaralingam, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1415-1415
Open Access | Times Cited: 14
Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment
Christopher A. Febres‐Aldana, Rachel Fanaroff, Michael Offin, et al.
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 11-42
Closed Access | Times Cited: 8
HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma
Joelle Sacks Suarez, Flavia Novelli, Keisuke Goto, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 39
Open Access | Times Cited: 7
BAP1 in cancer: epigenetic stability and genome integrity
Sabrina Caporali, Alessio Butera, Ivano Amelio
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling
Flavia Novelli, Yoshie Yoshikawa, Veronica Angela Maria Vitto, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 29
Open Access | Times Cited: 2
The Interplay Between the Immune System, Tumor Suppressor Genes, and Immune Senescence in Mesothelioma Development and Response to Immunotherapy
André E. Nel, Elizabeth N. Pavlisko, Victor L. Roggli
Journal of Thoracic Oncology (2023) Vol. 19, Iss. 4, pp. 551-564
Closed Access | Times Cited: 4
Identification of TNFRSF1A as a potential biomarker for osteosarcoma
Yuke Zhang, Kai Liu, Jianzhong Wang
Cancer Biomarkers (2024) Vol. 39, Iss. 4, pp. 299-312
Open Access | Times Cited: 1
High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma
Lianfen Wang, Xuesong Wang, Ning‐Ning Sun, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112039-112039
Closed Access | Times Cited: 1
Understanding the intersection between placental development and cancer: Lessons from the tumor suppressor BAP1
Paula Doria-Borrell, Vicente Pérez-García
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
The application of cancer stem cell model in malignant mesothelioma
Giuseppe Bronte, Antonio Domenico Procopio, Laura Graciotti
Critical Reviews in Oncology/Hematology (2022) Vol. 174, pp. 103698-103698
Closed Access | Times Cited: 5
The Multifaceted Roles of Autophagy in Infectious, Obstructive, and Malignant Airway Diseases
Marianna Carinci, Laura Palumbo, Giulia Pellielo, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1944-1944
Open Access | Times Cited: 5
Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound
Cristina Favaron, Ludovica Gaiaschi, Claudio Casali, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1015-1015
Open Access
Long noncoding RNA AK144717 exacerbates pathological cardiac hypertrophy through modulating the cellular distribution of HMGB1 and subsequent DNA damage response
Tianyu Wu, Yao Lu, Yue Yu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access
HDAC1: a promising target for cancer treatment: insights from a thorough analysis of tumor functions
Jun Xie, Rui Liu, Ying Cai, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5300-5315
Open Access
Page 1

Scroll to top